SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
29-Feb-24 7:56 PM View: | Moonlake Immunotherapeutics (MLTX) | 29-Feb-24 | Sale (Planned) | 4,740 | $55.89 | $264,919.00 | (< 1%) 2.99M to 2.98M | |
29-Feb-24 7:56 PM View: | Moonlake Immunotherapeutics (MLTX) | 28-Feb-24 | Sale (Planned) | 56,065 | $55.00 | $3,083,580.00 | (2%) 3.04M to 2.99M | |
29-Feb-24 7:56 PM View: | Moonlake Immunotherapeutics (MLTX) | 27-Feb-24 | Private Sale (Planned) | 62,810 | $55.00 | $3,454,550.00 | (2%) 3.11M to 3.04M | |
23-Feb-24 4:48 PM View: | Moonlake Immunotherapeutics (MLTX) | 21-Feb-24 | Private Sale (Planned) | 1,125 | $55.27 | $62,178.80 | (< 1%) 3.11M to 3.11M | |
20-Feb-24 6:36 PM View: | Moonlake Immunotherapeutics (MLTX) | 20-Feb-24 | Sale (Planned) | 20,000 | $57.44 | $1,148,800.00 | (< 1%) 3.13M to 3.11M | |
20-Feb-24 6:36 PM View: | Moonlake Immunotherapeutics (MLTX) | 16-Feb-24 | Sale (Planned) | 20,000 | $60.15 | $1,203,000.00 | (< 1%) 3.15M to 3.13M | |
20-Feb-24 6:36 PM View: | Moonlake Immunotherapeutics (MLTX) | 15-Feb-24 | Private Sale (Planned) | 20,000 | $60.18 | $1,203,600.00 | (< 1%) 3.17M to 3.15M | |
03-Oct-23 10:00 PM View: | Moonlake Immunotherapeutics (MLTX) | 01-Oct-23 | Conversion | 3,167,550 | -- | -- | 94% 3.38M to 6.55M | |
03-Oct-23 10:00 PM View: | Moonlake Immunotherapeutics (MLTX) | 01-Oct-23 | Disposition | 3,167,550 | -- | -- | (48%) 6.55M to 3.38M |